CD122 blockade restores immunological tolerance in autoimmune type 1 diabetes via multiple mechanisms

Por Yuan, Xiaomei, Dong, Yi, Tsurushita, Naoya, Tso, J. Yun, Fu, Wenxian
Publicado no JCI Insight (2018)

CD3 Ligation on Immature Thymocytes Generates Antagonist-like Signals Appropriate for CD8 Lineage Commitment, Independently of  T Cell Receptor Specificity

Por Albert Basson, M., Bommhardt, Ursula, Cole, Michael S., Tso, J. Yun, Zamoyska, Rose
Publicado em 1998

Nonmitogenic Anti-CD3 Monoclonal Antibodies Deliver a Partial T Cell Receptor Signal and Induce Clonal Anergy

Por Smith, Judith A., Tso, J. Yun, Clark, Marcus R., Cole, Michael S., Bluestone, Jeffrey A.
Publicado em 1997

CD122 signaling in CD8(+) memory T cells drives costimulation-independent rejection

Por Mathews, David V., Dong, Ying, Higginbotham, Laura B., Kim, Steven C., Breeden, Cynthia P., Stobert, Elizabeth A., Jenkins, Joseph, Tso, J. Yun, Larsen, Christian P., Adams, Andrew B.
Publicado no J Clin Invest (2018)

Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo

Por Richmond, Jillian M., Strassner, James P., Zapata, Lucio, Garg, Madhuri, Riding, Rebecca L., Refat, Maggi A., Fan, Xueli, Azzolino, Vincent, Tovar-Garza, Andrea, Tsurushita, Naoya, Pandya, Amit G., Tso, J. Yun, Harris, John E.
Publicado no Sci Transl Med (2018)